Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Potentially helpful for some: If you have certain health conditions, take medications that might interact, want to track metabolic improvements beyond the scale, or have specific health goals, selective lab testing might provide valuable information
The medication was discontinued in 2008 for commercial reasons and is now available off-label only through licensed US compounding pharmacies with a prescription
A randomized, placebo-controlled Phase 2 trial (NCT02453711) of once-daily subcutaneous semaglutide (0.05, 0.1, 0.2, 0.3, or 0.4 mg following 4-weekly escalations) in subjects with obesity without T2D, showed mean weight losses of -6.0% (0.05 mg) to -13.8% (0.4 mg) with semaglutide vs -2.3% with placebo at week 52
Pharmacokinetic predictions for patients with renal impairment: Focus on peptides and protein drugs
Strength & Fitness Programmes: Tailored plans to help preserve muscle mass and improve overall health
Unlike Viagra, which improves blood flow, PT-141 works on the brains arousal pathways
